Endra Life Sciences Inc.
13F holders, Q1 2024 (March 31)13holders
$0.58avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Endra Life Sciences Inc. in their 13F filings. The largest holders were Geode Capital Management, LLC ($31K), Two Sigma Securities, LLC ($28K) and Vanguard Group Inc. ($23K).
- Company
- Endra Life Sciences Inc.
- CUSIP
- 29273B302
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $75K |
| Exits | 3 | $8K |
Ownership 13 holders
| Geode Capital Management, LLC | 0.00% | Add +4.0% | 54,242 | $31K |
| Two Sigma Securities, LLC | 0.00% | New | 47,914 | $28K |
| Vanguard Group Inc. | 0.00% | No change | 39,812 | $23K |
| Jane Street Group, LLC | 0.00% | New | 36,115 | $21K |
| Virtu Financial LLC | 0.00% | New | 34,644 | $20K |
| NewEdge Advisors, LLC | 0.00% | Reduce -1.0% | 30,937 | $18K |
| XTX Topco Ltd | 0.00% | New | 10,758 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +190.2% | 8,656 | $5K |
| Morgan Stanley | 0.00% | No change | 332 | $193 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 329 | $191 |
| UBS Group AG | 0.00% | New | 140 | $81 |
| Wells Fargo & Company | 0.00% | Add +13.8% | 66 | $38 |
| FMR LLC | 0.00% | Add +1500.0% | 16 | $9 |
"% of holder's portfolio" is ENDRA LIFE SCIENCES INC's weight in each manager's 13F, not the share of Endra Life Sciences Inc. the manager owns.